AstraZeneca Halts Coronavirus Vaccine Trials Over Suspected Serious Adverse Reaction In Volunteer | WHAT REALLY HAPPENED

AstraZeneca Halts Coronavirus Vaccine Trials Over Suspected Serious Adverse Reaction In Volunteer

The British-Swedish drug giant AstraZeneca PLC announced Tuesday it had paused its late-stage trials of a potential COVID-19 vaccine after a study participant developed an unexplained illness.

The multinational pharmaceutical company had been testing a potential vaccine in the United Kingdom, where a volunteer suffered a severe possible side effect. The suspected adverse reaction to the drug prompted researchers to temporarily halt its program to conduct an investigation, the New York Times reported.

Pausing global trials is a standard precaution to ensure that experimental vaccines don’t cause severe reactions among volunteers. Vaccine trials often see several adverse events, such as fever, headaches, soreness, and muscle pain.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA